Page last updated: 2024-10-28

hexamethonium and Bowel Diseases, Inflammatory

hexamethonium has been researched along with Bowel Diseases, Inflammatory in 1 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with nicotine significantly decreased each of these markers in vagotomized mice with DSS colitis, and all markers except DAI and IL-6 in sham-operated DSS-treated mice."1.33The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. ( Blennerhassett, P; Collins, SM; Ghia, JE; Kumar-Ondiveeran, H; Verdu, EF, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghia, JE1
Blennerhassett, P1
Kumar-Ondiveeran, H1
Verdu, EF1
Collins, SM1

Other Studies

1 other study available for hexamethonium and Bowel Diseases, Inflammatory

ArticleYear
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.
    Gastroenterology, 2006, Volume: 131, Issue:4

    Topics: Animals; Anticoagulants; Appetite Depressants; Dextran Sulfate; Dinitrofluorobenzene; Disease Models

2006